Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome
Metalloproteinases In Medicine · 2017
DOI: 10.2147/mnm.s107246 ↗At a glance
Journal article in Metalloproteinases In Medicine, 2017. Written by Stephen Pflugfelder and 2 co-authors. Cited 23 times so far (Crossref). The full text is freely available (open access, CC BY-NC 3.0).
Abstract (original language)
Dry eye and tear dysfunction are common ocular disorders that cause cornea barrier disruption resulting in a poorly lubricated and irregular cornea epithelium, eye irritation and blurred vision. Increased levels and activities of matrix metalloproteinases (MMPs), particularly MMP-9, have been detected in the tears and ocular surface epithelial and inflammatory cells in dry eye. MMPs have been found to participate in disruption of tight junctions in the apical cornea epithelium leading to their accelerated desquamation and barrier disruption. This review summarizes evidence showing the contribution of MMPs to dry eye pathogenesis and their roles as biomarkers and therapeutic targets. Keywords: matrix metalloproteinase, dry eye, keratitis sicca, cornea, barrier function, Sjögren syndrome
Cite
APA
Pflugfelder, S., Fang, B., & Paiva, C. D. (2017). Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome. Metalloproteinases In Medicine. https://doi.org/10.2147/mnm.s107246
Vancouver
Pflugfelder S, Fang B, Paiva CD. Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome. Metalloproteinases In Medicine. 2017. doi:10.2147/mnm.s107246
BibTeX
@article{Pflugfelder2017,
author = {Pflugfelder, Stephen and Fang, Bian and Paiva, Cintia De},
title = {Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome},
journal = {Metalloproteinases In Medicine},
year = {2017},
doi = {10.2147/mnm.s107246}
}
EUVIMED